<DOC>
	<DOCNO>NCT00823173</DOCNO>
	<brief_summary>The purpose study determine whether ESBA105 , topically apply TNF-alpha inhibitor , safe clinically active apply eye patient suffer acute anterior uveitis</brief_summary>
	<brief_title>Exploratory Study Topical ESBA105 Acute Anterior Uveitis</brief_title>
	<detailed_description>Acute anterior uveitis ( AAU ) common , recurrent disease characterize inflammation iris ciliary body . Though usually effectively treated topical corticosteroid , novel treatment modality require overcome limitation adverse effect problem associate use corticosteroid . TNF-alpha recognized central disease mediator AAU , show preclinical model clinical data systemically apply TNF-alpha inhibitor . ESBA105 topically apply TNF-alpha inhibitor characterize efficient penetration eye result high intraocular drug level . A recently complete Phase I trial confirm safety tolerability topical ESBA105 healthy individual excellent systemic exposure low . In pilot trial , safety , local tolerability clinical activity topical ESBA105 treatment patient acute anterior uveitis shall explore .</detailed_description>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Uveitis , Anterior</mesh_term>
	<mesh_term>Iridocyclitis</mesh_term>
	<criteria>Signed date informed consent . Patients typical presentation HLAB27 positive AAU ( unilateral , painful anterior uveitis sudden onset ) . 2+ anterior chamber cell accord SUN Working Group criterion , assess slit lamp biomicroscopy . Start typical first symptoms current attack , define point time patient felt first sensation attack , within last 72 hour initiation treatment study medication . Negative pregnancy test female childbearing potential ( pre menopausal , &lt; 2 year postmenopausal , surgically sterile ) . Patients negative QuantiFERON TB Gold test result . Patients currently clinically apparent symptom HLA B27 associate acute extraocular disorder require systemic immunosuppressive therapy . Patients willing able cooperate study requirement . IOP elevation require therapy . Uncontrolled diabetes mellitus diabetic retinopathy . Patients single eye pinhole Snellen visual acuity 20/200 bad non study eye . Patients 1+ less anterior chamber cell . Patients 3+ 4+ anterior chamber cell hypopyon . Patients time begin current attack determine . Patients exhibit corneal ulceration history recurrent herpetic keratitis clinical evidence herpetic dermatitis . Patients currently treat topical corticosteroid . Patients treat systemic immunosuppressive therapy within last 2 month . Patients treat systemically administer TNFalpha inhibitor within last 2 month . Pregnant breastfeed woman woman childbearing potential , partner refuse use 2 reliable method contraception ( include 1 barrier method ) study . Male patient female partner could become pregnant refuse , partner , use 2 reliable method contraception ( include 1 barrier method ) study . Patients whose clinical presentation suggestive active bacterial , viral fungal infection anywhere body . Patients history recurrent infection , clinical presentation suggestive chronic infection require antimicrobial therapy ( e.g . syphilis ) include active episode serious viral infection , e.g . herpes simplex , herpes zoster , cytomegalic hepatitis virus clinical sign fungal infection , histoplasmosis , aspergillosis coccidiomycosis . Patients present high intraocular pressure uveitic eye contralateral eye . Patients know carrier status human immunodeficiency virus , hepatitis B hepatitis C. Patients history demyelinate disease ( multiple sclerosis ) optic neuritis . Patients positive unclear QuantiFERON TB Gold test result history high risk exposure Mycobacterium tuberculosis . Patients know coexist malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Uveitis</keyword>
	<keyword>TNF-alpha</keyword>
	<keyword>Topical</keyword>
	<keyword>ESBA105</keyword>
	<keyword>scFv antibody fragment</keyword>
	<keyword>ocular inflammation</keyword>
</DOC>